Home › Companies › Cardiff Oncology, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Cardiff Oncology, Inc.’s Form 8-K, filed 2026-06-11 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore Cardiff Oncology, Inc. in the interactive database Compare manager voting policies
These tallies are Cardiff Oncology, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-11 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Dr. James O. Armitage | 18,806,657 | 0 | 522,756 | -- | 22,285,435 | Majority: yes |
| Elect Director: Dr. Rodney Markin | 18,647,050 | 0 | 682,361 | -- | 22,285,437 | Majority: yes |
| Elect Director: Mani Mohindru, Ph.D. | 18,942,979 | 0 | 386,435 | -- | 22,285,434 | Majority: yes |
| Elect Director: Gary W. Pace, Ph.D. | 18,877,743 | 0 | 451,668 | -- | 22,285,437 | Majority: yes |
| Elect Director: Renee P. Tannenbaum, Pharm.D. | 18,790,068 | 0 | 539,345 | -- | 22,285,435 | Majority: yes |
| Elect Director: Lâle White | 18,710,040 | 0 | 619,373 | -- | 22,285,435 | Majority: yes |
| Proposal 4. The advisory vote on the compensation of the Company's named executive officers was approved by the stockholders by the votes set forth in the table below: | 17,120,176 | 1,772,185 | 437,049 | -- | 22,285,438 | Majority: yes |
Source: Cardiff Oncology, Inc., Form 8-K, filed with the SEC on 2026-06-11 — read the filing on EDGAR.
Each item below shows how the 108 asset managers that disclosed a Cardiff Oncology, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Cardiff Oncology, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Cardiff Oncology, Inc.’s own tally for this item (“Proposal 4. The advisory vote on the compensation of the Company's named executive officers was approved by the stockholders by the votes set forth in the table below:”): 17,120,176 for, 1,772,185 against, per its Form 8-K filed 2026-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,369,896 outstanding shares: 25% for, 3% against (28% of the company cast a for/against vote).
The 108 asset managers below cast 99.9% of the shares they voted on this item FOR (10,573,349 for, 8,439 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Laurion Capital Management LP | 2,628,583 | 0 | 0 | 0 | For |
| PFIZER INC | 2,411,575 | 0 | 0 | 0 | For |
| ACORN CAPITAL ADVISORS, LLC | 1,062,084 | 0 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 717,028 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 647,703 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Putnam | 434,407 | 0 | 0 | 0 | For |
| BlackRock | 412,895 | 50 | 0 | 0 | For |
| State Street | 356,417 | 1,683 | 0 | 0 | For |
| Northern Trust | 251,715 | 2,050 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 136,390 | 0 | 0 | 0 | For |
| Vanguard | 117,905 | 1 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 108,956 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 56,500 | 0 | 0 | 0 | For |
| Nuveen | 56,249 | 0 | 0 | 0 | For |
| CAPSTONE INVESTMENT ADVISORS, LLC | 51,190 | 0 | 0 | 0 | For |
| AllianceBernstein | 48,730 | 0 | 0 | 0 | For |
| Fidelity | 48,491 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Glenview Trust Co | 43,128 | 0 | 0 | 0 | For |
| Two Sigma | 39,547 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 38,088 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Baker Ellis Asset Management LLC | 20,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Combines 3 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Dr. James O. Armitage”): 18,806,657 for, 0 against, per its Form 8-K filed 2026-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,369,896 outstanding shares: 28% for, 0% against (28% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (844,159 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,443 | 0 | 0 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 5,678 | 0 | Abstain |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 3 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Dr. Rodney Markin”): 18,647,050 for, 0 against, per its Form 8-K filed 2026-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,369,896 outstanding shares: 27% for, 0% against (27% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (843,530 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 106,814 | 0 | 630 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 5,678 | 0 | Abstain |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 3 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Gary W. Pace, Ph.D.”): 18,877,743 for, 0 against, per its Form 8-K filed 2026-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,369,896 outstanding shares: 28% for, 0% against (28% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (843,953 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,237 | 0 | 206 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 5,678 | 0 | Abstain |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 4 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Lâle White”): 18,710,040 for, 0 against, per its Form 8-K filed 2026-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,369,896 outstanding shares: 27% for, 0% against (27% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (849,837 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,443 | 0 | 0 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 5,678 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 3 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Mani Mohindru, Ph.D.”): 18,942,979 for, 0 against, per its Form 8-K filed 2026-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,369,896 outstanding shares: 28% for, 0% against (28% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (849,414 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,020 | 0 | 424 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 5,678 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 3 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Renee P. Tannenbaum, Pharm.D.”): 18,790,068 for, 0 against, per its Form 8-K filed 2026-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,369,896 outstanding shares: 27% for, 0% against (27% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (843,736 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,020 | 0 | 424 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 5,678 | 0 | Abstain |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
36% fund support · no official result
The 32 asset managers below cast 36% of the shares they voted on this item FOR (303,058 for, 546,779 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 0 | 438,961 | 0 | 0 | Against |
| Vanguard | 107,016 | 427 | 0 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 44,100 | 0 | 0 | Against |
| Equitable | 13,053 | 30,180 | 0 | 0 | Against |
| Fidelity | 34,539 | 3,182 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 6,767 | 0 | 0 | Against |
| Calvert | 0 | 5,678 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 0 | 4,557 | 0 | 0 | Against |
| ProShares | 0 | 3,636 | 0 | 0 | Against |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 0 | 2,430 | 0 | 0 | Against |
| PENN SERIES FUNDS INC | 0 | 1,600 | 0 | 0 | Against |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 1,563 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 1,300 | 0 | 0 | Against |
| Voya | 0 | 806 | 0 | 0 | Against |
| John Hancock | 0 | 589 | 0 | 0 | Against |
| Guggenheim | 0 | 565 | 0 | 0 | Against |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
100% fund support · no official result
The 32 asset managers below cast 100% of the shares they voted on this item FOR (849,837 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,443 | 0 | 0 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 5,678 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Ranked by the number of Cardiff Oncology, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 68,369,896 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Laurion Capital Management LP | 3.84% |
| 2 | PFIZER INC | 3.53% |
| 3 | ACORN CAPITAL ADVISORS, LLC | 1.55% |
| 4 | BLAIR WILLIAM & CO/IL | 1.05% |
| 5 | FRANKLIN ADVISERS INC | 0.95% |
| 6 | FRANKLIN STRATEGIC SERIES | 0.64% |
| 7 | Putnam | 0.64% |
| 8 | BlackRock | 0.60% |
| 9 | State Street | 0.52% |
| 10 | Northern Trust | 0.37% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 5.82% | 13F |
| Vanguard Group | 5.44% | 13F |
| Gary W. Pace, Ph.D. | 3.26% | DEF14A |
| Mark Erlander, Ph.D. | 3.08% | DEF14A |
| Geode Capital | 2.34% | 13F |
| Franklin Templeton | 1.76% | 13F |
| State Street | 1.74% | 13F |
| James Levine | 1.41% | DEF14A |
| Northern Trust | 0.72% | 13F |
| Mani Mohindru, Ph.D. | 0.63% | DEF14A |
Percentages above are of 68,369,896 shares outstanding, as reported by Cardiff Oncology, Inc. on its Form 10-Q dated 2026-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Cardiff Oncology, Inc.’s 10-Q dated 2026-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Cardiff Oncology, Inc.'s shareholder meeting held 2026-06-11, in the 2025-2026 proxy season, 108 asset managers reported how they voted in their SEC Form N-PX filings, covering 917 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Proposal to approve, on an advisory basis, the compensation of the Company's named executive… — FOR was 91% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Cardiff Oncology, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-11.
Cardiff Oncology, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).